Skip to Content

V920 Approval Status

FDA Approved: No
Brand name: V920
Generic name: rVSV∆G-ZEBOV-GP, live attenuated
Company: Merck
Treatment for: Ebola Zaire Disease Prophylaxis

V920 (rVSV∆G-ZEBOV-GP, live attenuated) is an investigational vaccine for Ebola Zaire disease.

Development Status and FDA Approval Process for V920

Nov 13, 2018Merck Begins Rolling Submission of Licensure Application for V920 (rVSV∆G-ZEBOV-GP) to U.S. Food and Drug Administration

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.